A new two step procedure for 4.5 log depletion of t and b cells in allogeneic transplantation and of neoplastic cells in autologous transplantation

F. Bertolinl, T. Thomas, M. Baflaqlia, N. Gibelli, P. Pedrazzoli, G. Robustem Delà Cuna

Research output: Contribution to journalArticle

Abstract

In HLA-mlsmatched or aploidentlcal aHogeneic progenitor cell (PC) transplantation, T cell removal can control graft vs host disease, and B cell removal might reduce the incidence of some viral diseases. In autologous transplantation, purging of contaminating neoplastic ceKs might reduce the incidence of relapse. To study a new two step PC purging procedure combining positive and negative selection, PC were collected by apheresis from cancer patients, and an aliquot was first processed through CellPro columns for CD34+ cell positive selection. On some occasions, PC samples were deliberately contaminated by 1-5% breast cancer oeH lines CG5 and CAMA-1. After this first positive selection step, mean CD34+ cell recovery was S6±12%, and CD34+ cell purity was 63±12% At this Urne. CD3+ and neoplastic cell depletion (assessed by APAAP staining of 1x107 cells) were 2 10.7 and 1 8±0 6 logs, respectively. CD34+ cells were further processed through the StemSep(tm) negative selection device for immunoaffinity removal of T and B cells by means of anti-CD3 and anti-CD19 antibodies (n-6) or of breast cancer cells from contaminated PC samples by means of 5E11 antibody (n=4). After the first and the second step, results were as follows: CD34+ recovery CD34+ purity log depletion T and B cell removal 4719 94±B 4.8±0.4 Breast cancer removal 52±11 73±15 4.3±0.4 This new procedure is associated with an acceptable loss of CD34+ cells and a T/B and neoplastic cell purging of 4.5 logs, ie significantly superior than methods previously described.

Original languageEnglish
Pages (from-to)1136
Number of pages1
JournalExperimental Hematology
Volume24
Issue number9
Publication statusPublished - 1996

Fingerprint

Autologous Transplantation
Homologous Transplantation
Stem Cells
B-Lymphocytes
Breast Neoplasms
T-Lymphocytes
Device Removal
Blood Component Removal
Incidence
Cell Transplantation
Graft vs Host Disease
Virus Diseases
Anti-Idiotypic Antibodies
Staining and Labeling
Recurrence
Antibodies

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

A new two step procedure for 4.5 log depletion of t and b cells in allogeneic transplantation and of neoplastic cells in autologous transplantation. / Bertolinl, F.; Thomas, T.; Baflaqlia, M.; Gibelli, N.; Pedrazzoli, P.; Cuna, G. Robustem Delà.

In: Experimental Hematology, Vol. 24, No. 9, 1996, p. 1136.

Research output: Contribution to journalArticle

@article{711d6d0fcf4d444dab17310e64d10fa2,
title = "A new two step procedure for 4.5 log depletion of t and b cells in allogeneic transplantation and of neoplastic cells in autologous transplantation",
abstract = "In HLA-mlsmatched or aploidentlcal aHogeneic progenitor cell (PC) transplantation, T cell removal can control graft vs host disease, and B cell removal might reduce the incidence of some viral diseases. In autologous transplantation, purging of contaminating neoplastic ceKs might reduce the incidence of relapse. To study a new two step PC purging procedure combining positive and negative selection, PC were collected by apheresis from cancer patients, and an aliquot was first processed through CellPro columns for CD34+ cell positive selection. On some occasions, PC samples were deliberately contaminated by 1-5{\%} breast cancer oeH lines CG5 and CAMA-1. After this first positive selection step, mean CD34+ cell recovery was S6±12{\%}, and CD34+ cell purity was 63±12{\%} At this Urne. CD3+ and neoplastic cell depletion (assessed by APAAP staining of 1x107 cells) were 2 10.7 and 1 8±0 6 logs, respectively. CD34+ cells were further processed through the StemSep(tm) negative selection device for immunoaffinity removal of T and B cells by means of anti-CD3 and anti-CD19 antibodies (n-6) or of breast cancer cells from contaminated PC samples by means of 5E11 antibody (n=4). After the first and the second step, results were as follows: CD34+ recovery CD34+ purity log depletion T and B cell removal 4719 94±B 4.8±0.4 Breast cancer removal 52±11 73±15 4.3±0.4 This new procedure is associated with an acceptable loss of CD34+ cells and a T/B and neoplastic cell purging of 4.5 logs, ie significantly superior than methods previously described.",
author = "F. Bertolinl and T. Thomas and M. Baflaqlia and N. Gibelli and P. Pedrazzoli and Cuna, {G. Robustem Del{\`a}}",
year = "1996",
language = "English",
volume = "24",
pages = "1136",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - A new two step procedure for 4.5 log depletion of t and b cells in allogeneic transplantation and of neoplastic cells in autologous transplantation

AU - Bertolinl, F.

AU - Thomas, T.

AU - Baflaqlia, M.

AU - Gibelli, N.

AU - Pedrazzoli, P.

AU - Cuna, G. Robustem Delà

PY - 1996

Y1 - 1996

N2 - In HLA-mlsmatched or aploidentlcal aHogeneic progenitor cell (PC) transplantation, T cell removal can control graft vs host disease, and B cell removal might reduce the incidence of some viral diseases. In autologous transplantation, purging of contaminating neoplastic ceKs might reduce the incidence of relapse. To study a new two step PC purging procedure combining positive and negative selection, PC were collected by apheresis from cancer patients, and an aliquot was first processed through CellPro columns for CD34+ cell positive selection. On some occasions, PC samples were deliberately contaminated by 1-5% breast cancer oeH lines CG5 and CAMA-1. After this first positive selection step, mean CD34+ cell recovery was S6±12%, and CD34+ cell purity was 63±12% At this Urne. CD3+ and neoplastic cell depletion (assessed by APAAP staining of 1x107 cells) were 2 10.7 and 1 8±0 6 logs, respectively. CD34+ cells were further processed through the StemSep(tm) negative selection device for immunoaffinity removal of T and B cells by means of anti-CD3 and anti-CD19 antibodies (n-6) or of breast cancer cells from contaminated PC samples by means of 5E11 antibody (n=4). After the first and the second step, results were as follows: CD34+ recovery CD34+ purity log depletion T and B cell removal 4719 94±B 4.8±0.4 Breast cancer removal 52±11 73±15 4.3±0.4 This new procedure is associated with an acceptable loss of CD34+ cells and a T/B and neoplastic cell purging of 4.5 logs, ie significantly superior than methods previously described.

AB - In HLA-mlsmatched or aploidentlcal aHogeneic progenitor cell (PC) transplantation, T cell removal can control graft vs host disease, and B cell removal might reduce the incidence of some viral diseases. In autologous transplantation, purging of contaminating neoplastic ceKs might reduce the incidence of relapse. To study a new two step PC purging procedure combining positive and negative selection, PC were collected by apheresis from cancer patients, and an aliquot was first processed through CellPro columns for CD34+ cell positive selection. On some occasions, PC samples were deliberately contaminated by 1-5% breast cancer oeH lines CG5 and CAMA-1. After this first positive selection step, mean CD34+ cell recovery was S6±12%, and CD34+ cell purity was 63±12% At this Urne. CD3+ and neoplastic cell depletion (assessed by APAAP staining of 1x107 cells) were 2 10.7 and 1 8±0 6 logs, respectively. CD34+ cells were further processed through the StemSep(tm) negative selection device for immunoaffinity removal of T and B cells by means of anti-CD3 and anti-CD19 antibodies (n-6) or of breast cancer cells from contaminated PC samples by means of 5E11 antibody (n=4). After the first and the second step, results were as follows: CD34+ recovery CD34+ purity log depletion T and B cell removal 4719 94±B 4.8±0.4 Breast cancer removal 52±11 73±15 4.3±0.4 This new procedure is associated with an acceptable loss of CD34+ cells and a T/B and neoplastic cell purging of 4.5 logs, ie significantly superior than methods previously described.

UR - http://www.scopus.com/inward/record.url?scp=33748625985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748625985&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748625985

VL - 24

SP - 1136

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -